SCHEMBL23366394

SCHEMBL23366394

COCONCCNC(=O)c1cc2c(Cl)c(Cl)ccc2n1C

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PHGDH O43175 12/20 0.47
HPGD P15428 4/20 0.43
ALDH1A1 P00352 3/20 0.43
KDM4E B2RXH2 2/20 0.43
HSD17B10 Q99714 2/20 0.43
MAPK1 P28482 2/20 0.42
POLB P06746 1/20 0.39
PKM P14618 1/20 0.38
RAB9A P51151 1/20 0.38
THRB P10828 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38
RECQL P46063 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19344152 0.83 PHGDH (0.53) PHGDHHPGDALDH1A1KDM4EHSD17B10
SCHEMBL19343635 0.82 PHGDH (0.55) PHGDHHPGDALDH1A1KDM4EHSD17B10
SCHEMBL19344109 0.80 PHGDH (0.53) PHGDHHPGDALDH1A1KDM4EHSD17B10
SCHEMBL25538844 0.80 PHGDH (0.57) PHGDHHSD17B10THRBRXFP1MAPT
SCHEMBL19342030 0.79 PHGDH (0.47) PHGDHHPGDALDH1A1KDM4EHSD17B10
SCHEMBL19347345 0.78 PHGDH (0.51) PHGDHHPGDALDH1A1KDM4EHSD17B10
SCHEMBL26326346 0.78 PHGDH (0.51) PHGDHHPGDALDH1A1KDM4EHSD17B10
SCHEMBL23366395 0.78 PHGDH (0.51) PHGDHHPGDALDH1A1KDM4EHSD17B10
SCHEMBL23366358 0.78 PHGDH (0.48) PHGDHHPGDALDH1A1KDM4EHSD17B10
SCHEMBL20793451 0.77 PHGDH (0.53) PHGDHHPGDALDH1A1KDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3884939-B1 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF RAZE THERAPEUTICS INC (US) 2023-10-25 EP disclosed
EP-3426243-B1 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF RAZE THERAPEUTICS INC (US) 2021-05-19 EP disclosed